The results demonstrated that the expression of c-Myc, cyclin D1, cyclin A, and E2F1 decreased after knocking down TFE3, suggesting that the TFE3-mediated overexpression of HOXD-AS2 promoted the cell cycle progression in glioma cells. The gene discussed is MYC; the disease is central nervous system cancer.